Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Viraemia”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Not applicableStudy completedNCT02784756
What this trial is testing

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Viraemia
University Health Network, Toronto 134
Testing effectiveness (Phase 2)Study completedNCT02136797
What this trial is testing

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
CMV InfectionPersistent CMV Viremia
Memorial Sloan Kettering Cancer Center 77
Post-approval studies (Phase 4)Study completedNCT00947141
What this trial is testing

Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

Who this might be right for
Viraemia
University College, London 165
Not applicableUnknownNCT01397058
What this trial is testing

Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress

Who this might be right for
Cytomegalovirus ViraemiaStress, PhysiologicalReceptor, Hormonal; Disorder+1 more
University of Athens 275
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06971913
What this trial is testing

Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

Who this might be right for
SLE (Systemic Lupus)CMV
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06059391
What this trial is testing

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
City of Hope Medical Center 216
Early research (Phase 1)Active Not RecruitingNCT03560752
What this trial is testing

CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 34
Not applicableLooking for participantsNCT07294547
What this trial is testing

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

Who this might be right for
Kidney Transplantation, Cytomegalovirus InfectionsEBV InfectionAntiviral Prophylaxis
National Taiwan University Hospital 80
Not applicableLooking for participantsNCT06341543
What this trial is testing

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

Who this might be right for
Cytomegalovirus InfectionsHeart TransplantationKidney Transplantation+2 more
University Hospital, Grenoble 288
Testing effectiveness (Phase 2)Looking for participantsNCT05432778
What this trial is testing

Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients

Who this might be right for
CMV Viremia
University Medical Centre Ljubljana 90
Testing effectiveness (Phase 2)Study completedNCT01329185
What this trial is testing

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

Who this might be right for
EBV ViremiaCMV Viremia
University of Minnesota 17
Large-scale testing (Phase 3)Study completedNCT00006145
What this trial is testing

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 350
Testing effectiveness (Phase 2)Study completedNCT04018261
What this trial is testing

Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients

Who this might be right for
CMV ViremiaImmunosuppression-related Infectious Disease
Banc de Sang i Teixits 26
Not applicableUnknownNCT00004573
What this trial is testing

Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR

Who this might be right for
Cytomegalovirus Infections
National Center for Research Resources (NCRR)
Large-scale testing (Phase 3)Looking for participantsNCT07079735
What this trial is testing

Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant

Who this might be right for
CMV ViremiaHeart Transplant InfectionHeart Transplant Failure and Rejection
Columbia University 150
Not applicableUnknownNCT06339892
What this trial is testing

HCMV Breakthrough Infections During Letermovir Prophylaxis

Who this might be right for
Cytomegalovirus InfectionsCytomegalovirus ViremiaHematopoietic Stem Cell Transplantation
Fondazione IRCCS Policlinico San Matteo di Pavia 140
Not applicableUnknownNCT06263218
What this trial is testing

Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil

Who this might be right for
CMV InfectionCMV Viremia
Hospital do Rim e Hipertensão 500
Not applicableStudy completedNCT03443791
What this trial is testing

Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation

Who this might be right for
Cmv CongenitalCMV Viremia
University of Alabama at Birmingham 200
Early research (Phase 1)Ended earlyNCT03798301
What this trial is testing

Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells

Who this might be right for
CMV InfectionCytomegalovirus InfectionsCMV Viremia+1 more
University of Wisconsin, Madison 3
Testing effectiveness (Phase 2)Looking for participantsNCT07383649
What this trial is testing

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

Who this might be right for
Brain Cancer MetastaticCMV Viremia
The Methodist Hospital Research Institute 28
Load More Results